NASDAQ: NRXP · Biotechnology
Over the past week, NRX Pharmaceuticals (NRXP) pulled in 15 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 18% bullish but is far apart: Reddit runs 54% bullish while News sits at just 0%. Wall Street is more constructive, with 4 of 4 analysts rating NRXP a buy.
There is little buzz around NRXP this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 100% buy share sits next to a crowd that ranges from News at 0% to Reddit at 54%. No other tracker puts the two side by side.
Across 4 analysts the consensus is a Strong Buy: 4 buy calls against 0 sell, with an average 12-month price target of $38.50.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 82 points above the crowd average of 18%, the professionals are more constructive than retail. The split is inside the crowd: Reddit reads 54% bullish while News sits at 0%, a 54-point spread that single-source trackers miss.
Over the 30-day window, NRX Pharmaceuticals (NRXP) buzz held subdued around 25.0 while the price drifted down 16.2% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 680K shares. Updated Oct 10, 2026. Over the last 7 trading days, NRXP held roughly flat. Buzz activity in the recent week averaged 26.1 and was variable, swinging between 10.2 and 43.2. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 10 of the 15 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for NRXP and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live NRXP sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 10, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (4 / 0 / 0) |
| Crowd bullish (7d) | 18% |
| Avg price target | $38.50 |
| Most bullish source | Reddit, 54% |
| Most bearish source | News, 0% |
| Sentiment spread | 54 pts |
| Mentions (7d) | 15 |
| Market cap | $125.1M |
| P/E · Forward P/E | n/a · 34.3 |
| EPS · Beta | -$0.58 · 2.1 |
| Revenue (TTM) | $3.4M · 0% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, NRX Pharmaceuticals (NRXP) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 18% bullish across 3 active sources. Those sources contribute 15 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around NRX Pharmaceuticals (NRXP) is fairly quiet with 13 mentions over the last 7 days; the 30-day context spans 7 tracked subreddits. The 7-day tone is 54% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on NRX Pharmaceuticals (NRXP), averaging 18% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 54% bullish and News at 0%, a 54-point spread. On the professional side, 4 of 4 analysts rate NRXP a buy.
Of the 4 analysts covering NRX Pharmaceuticals (NRXP), 4 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $38.50. That puts the street ahead of the crowd, which averages 18% bullish.
NRX Pharmaceuticals (NRXP)'s cross-source average is bearish at 18% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. Reddit reads 54% bullish, News reads 0% bullish and x coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for NRX Pharmaceuticals (NRXP) at 18% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. The most bearish reading is x at 0% bullish. The sell signal carries 93/100 conviction.
Reddit is the dominant discussion channel with 13 mentions (87% of total volume). News contributes 2 mentions. The cross-source average is bearish at 18% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. NRXP's sell signal at 93/100 conviction reflects a bearish cross-source average at 18% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. It is a research shortcut, not financial advice.
The NRXP sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key